Neuroleptic malignant syndrome: need for early diagnosis and therapy.

Humaira M. Khan, Nadir A. Syed, Mughis Sheerani, Bhojo Khcalani, Ayeesha Kamal, Mohammad Wasay

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)


BACKGROUND: Neuroleptic Malignant Syndrome (NMS) is a medical entity that has received little attention in the clinical settings in Pakistan. The aim of our study was to review the predisposing factors, outcomes and characteristics of in-patients diagnosed with NMS. METHODS: We performed a retrospective chart review of all cases (age >15 years) at a tertiary care center in Karachi between January 01, 1990 and November 30, 2001, diagnosed using ICD 10 coding. Data was collected using a standardized data entry form and statistical analysis was performed using Epi Info 6, Version 6.02. RESULTS: There were a total of 20 patients diagnosed with NMS (11 male and 9 female) in our study with a mean age of 46.6 +/- 15.9 years. Haloperidol was the most frequently responsible neuroleptic. Of the 18 patients on a neuroleptic, most developed NMS after 8 weeks of therapy. There were 5 mortalities all of which were associated with septic shock. Fourteen patients recovered completely from the episode and did not have any neurologic sequelae. CONCLUSIONS: NMS is an important preventable clinical entity. Early diagnosis and judicious use of antipsychotics is warranted to prevent mortality and heightened morbidity.

Original languageEnglish
Pages (from-to)17-21
Number of pages5
JournalJournal of Ayub Medical College, Abbottabad : JAMC
Issue number1
Publication statusPublished - 2006


Dive into the research topics of 'Neuroleptic malignant syndrome: need for early diagnosis and therapy.'. Together they form a unique fingerprint.

Cite this